Results 71 to 80 of about 4,505 (178)

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults

Clinical Medicine Insights: Endocrinology and Diabetes, 2013
Type 2 diabetes affects millions of people worldwide and significantly contributes to morbidity and mortality of those affected by it. Current guidelines recommend individualized treatment regimens following first line metformin therapy.
Molly G. Minze, Mary S. Klein, Brian T. Terrell   +2 more
doaj   +1 more source

Comparison of adherence and persistence among adults with type 2 diabetes mellitus initiating saxagliptin or linagliptin

Patient Preference and Adherence, 2016
Amanda M Farr,1 John Jack Sheehan,2 Brian M Davis,1 David M Smith1 1Life Sciences, Truven Health Analytics, an IBM Company, Cambridge, MA, 2Health Economics and Outcomes Research – Diabetes, AstraZeneca, Fort Washington, PA, USA Background ...
Farr AM, Sheehan JJ, Davis BM, Smith DM
doaj  

Identification of Reactive Metabolites of Acetaminophen and Saxagliptin in Human Hepatocytes and Hepatic Organoids. [PDF]

Pharmaceutics
Song IS, Pang M, Lee MS, Lee J, Liu KH, Choi MK, Park HJ, Kim H, Lee HS.   +8 more
europepmc   +1 more source

Aspartame may promote erectile dysfunction via DPP4-mediated endothelial dysfunction and apoptosis: evidence from network toxicology, molecular dynamics simulation, and experimental validation. [PDF]

Front Nutr
Dai Z, Wang S, Chen Z, Zhang Q, Wang B.
europepmc   +1 more source

METTL3 inhibition attenuates AFB₁-induced hepatic fibrosis by suppressing m⁶A-mediated hepatic stellate cell activation. [PDF]

J Anim Sci Biotechnol
Zhao Y, Feng Y, Yuan W, Zhang T, Zhao R.
europepmc   +1 more source

Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS. [PDF]

In Vivo
Ohyama K, Takahashi T, Akiyama S, Hori Y.   +3 more
europepmc   +1 more source

Eco-friendly spectrophotometric approach for the determination of anti-diabetic drugs in fixed-dose formulation together with metformin's toxic impurity: comprehensive method assessment. [PDF]

Sci Rep
Mohamed DG, Abdelrahman MM, Ahmed AB, Magdy MA.   +3 more
europepmc   +1 more source

Authors' Response to "Comment on 'SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis'". [PDF]

J Transl Med
Rostami-Afshari B, Elremaly W, Franco A, Moreau A.   +3 more
europepmc   +1 more source

Efficacy and safety of novel antidiabetic drugs in patients with type 2 diabetes and chronic kidney disease: a network meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Zhu X, Wang X, Zhang P, Yang Z, Zhao N, Li J, Shi Y, Zhao Y, Ma J.   +8 more
europepmc   +1 more source

Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS). [PDF]

PLoS One
Xiong W, Li Y, Huang J, He G, Sun J.
europepmc   +1 more source